IQCD: A Potential Drug Target and Biomarker for Cancer (G115811)

Target Name: IQCD

NCBI ID: G115811

IQCD

IQCD: A Potential Drug Target and Biomarker for Cancer

IQCD (IQC螖CD) is a protein that is expressed in the human placenta and has been shown to play a role in the development and progression of various diseases, including cancer. It is a member of the Integrin alpha-2 (Igp2) family, which is known for its role in cell-cell adhesion and migration.

Recent studies have identified IQCD as a potential drug target for the treatment of various diseases, including cancer. One of the main reasons for its potential as a drug target is its high expression level in the human placenta, which suggests that it may be involved in the development and progression of these diseases. Additionally, IQCD has been shown to interact with several other proteins, including the transcription factor NF-kappa-B, which is known for its role in cancer progression.

IQCD is also of interest as a biomarker for several diseases, including cancer. Its high expression level in the placenta may make it an useful indicator of disease status, particularly in cases where cancer has been detected. Additionally, IQCD has been shown to be downregulated in several types of cancer, which may make it an potential target for cancer therapies.

In addition to its potential as a drug target and biomarker, IQCD is also of interest as a potential therapeutic approach for several diseases. For example, IQCD has been shown to have anti-inflammatory effects, which may make it an attractive candidate for the treatment of diseases that are characterized by chronic inflammation, such as cancer. Additionally, its role in cell-cell adhesion and migration may make it an attractive candidate for the treatment of diseases that are characterized by the movement of cells, such as cancer.

Overall, IQCD is a protein that has the potential to be a drug target and biomarker for several diseases, including cancer. Its high expression level in the human placenta and its interaction with important proteins, including NF-kappa-B, make it an attractive candidate for further study. Further research is needed to fully understand its role in disease and to determine its potential as a therapeutic approach.

Protein Name: IQ Motif Containing D

Functions: Component of the nexin-dynein regulatory complex (N-DRC), a key regulator of ciliary/flagellar motility which maintains the alignment and integrity of the distal axoneme and regulates microtubule sliding in motile axonemes

The "IQCD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IQCD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets